Isomorphic Labs Prepares for Landmark Human Trials of AI-Designed Drugs
Isomorphic Labs Prepares for Landmark Human Trials of AI-Designed Drugs Alphabet’s secretive drug discovery arm, Isomorphic Labs, is on the cusp of a major breakthrough, gearing up to commence human clinical trials for its groundbreaking AI-designed pharmaceuticals. This pivotal development marks a significant step towards realizing the company’s ambitious goal of revolutionizing medicine through artificial intelligence. Colin Murdoch, President of Isomorphic Labs and Chief Business Officer of Google DeepMind, confirmed that teams are actively working with AI to design drugs,…